Drug
Srp 9004
Srp 9004: highest development phase Phase 1/2, developed by Sarepta Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| SRP-9004 NCT01976091 | Phase 1/2 | Limb-Girdle Muscular Dystrophy, Type 2D |
| SRP-9004 NCT06747273 | Phase 1 | Limb Girdle Muscular Dystrophy |
Latest
No recent events.
Follow Srp 9004 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.